Matinas BioPharma Holdings, Inc. (MTNB): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$218.0K
Year ended 2023-12-31
+236.0%
3-year compound annual growth
-16.5%
5-year compound annual growth
+8.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $218.0K | -75.6% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $892.0K | +243.1% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $260.0K | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $5.7K | -98.6% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $405.6K | -24.3% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $535.9K | -43.1% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $942.2K | n/a | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $0 | -100.0% | 2017-03-31, From 2016-01-01 |
| 2015-12-31 | $76.2K | -73.6% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $288.5K | +206.3% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $94.2K | n/a | 2015-03-31, From 2013-01-01 |